VR headsets beat Pre-Surgery jitters in heart patients

NCT ID NCT04242563

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether using virtual reality (VR) in the waiting room could reduce anxiety in 156 adults about to undergo a heart catheterization. Participants used VR while waiting for their procedure, and researchers measured their stress levels using heart rate monitors and surveys. The goal was to see if a simple, drug-free distraction could make the pre-surgery experience less stressful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

156 people

The number who actually took part.

Started

Feb 2020

Finished

Jul 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Major male or female patient * Coronarography procedure programmed for exploration of coronary artery disease following a positive ischemia test, realized in ambulatory * Patient who has given written consent to participate in the study Exclusion Criteria: * Arrhythmia patient and / or patient with a pacemaker * Hemodynamic instability * Patient who has already had coronarography * Prior revascularization by coronary bypass * End-stage renal disease (Creatinine clearance \<30 ml / min), * Allergy to iodine contrast agent * Blind or visually impaired patient (high degree) * Deaf or hard of hearing patient * Patient with claustrophobia or unable to wear a mask over the eyes * Patient whose physical or psychological state could compromise obtaining informed consent and compliance with protocol requirements * Patient under administrative or judicial supervision * Foreign patient who does not understand French * Major patient protected by law (article L1121-8 and L1121-5) * Pregnant or lactating patient * Patient not affiliated with social security

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Grenoble University Hospital

    Grenoble, 38043, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.